Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday

AIR Global shares are trading higher after a Form 4 filing showed its CFO bought additional 50 shares at an average price of $7.50 each.

Gap Posts Upbeat Q2 Earnings, Joins Solstice Advanced Materials, N-Able And Other Big Stocks Moving Higher On Friday

U.S. stocks mixed, Nasdaq falls 0.1%. Gap Inc shares rise 15.2% on strong earnings and raised guidance. Other big gainers include Elastic NV, Solstice Advanced Materials Inc, and Pagerduty Inc.

AIR Announces Results of Extraordinary General Meeting of Shareholders

AIR Global PLC shareholders approved the repurchase of 5 million ordinary shares from Harraden Circle Investors for $52.45 million at $10.49 per share. The company also received general authorities to conduct future share repurchases through off-market and open market transactions. Additionally, shareholders approved amendments to the company's articles of association regarding meeting notices.

How BioMarin Turned a Competitive Threat Into a Royalty-Bearing Asset

BioMarin settled a patent dispute with Ascendis Pharma over the achondroplasia drug Yuviwel, converting a competitive threat into a royalty stream. Under the agreement, BioMarin will receive 20% royalties on U.S. Yuviwel sales and 18% in the EU, Brazil, and South Korea through May 2030. While this monetizes competition, BioMarin still faces market pressure from Yuviwel and potential future competitors like BridgeBio's infigratinib.

Oppenheimer Maintains Outperform on Ascendis Pharma, Raises Price Target to $312

Morgan Stanley Maintains Overweight on Ascendis Pharma, Lowers Price Target to $273